EUVIMEDEUVIMED entdecken
Crossref

A Bispecific Peptide–Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells

Yuzhen Qian, Yixuan Sun, Yahong Wu, Yi Liu, Xiuman Zhou, Haoming Ning, Youmei Xiao, Xueqin Zhu, Xuefu Zhou, Xiaoshuang Niu, Wenjie Zhai, Yanfeng Gao iD

Journal of Medicinal Chemistry · 09.04.2026 · 69 (7) · 7839-7855

DOI: 10.1021/acs.jmedchem.5c03115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.03.2026. Verfasst von Yuzhen Qian und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Macrophages, Antigens, CD, T-Lymphocytes, B7-H1 Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, Science and Technology Foundation of Shenzhen City, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesAntigens, CDT-LymphocytesB7-H1 AntigenPeptidesAntineoplastic AgentsAnimalsLymphocyte Activation Gene 3 ProteinMiceToll-Like Receptor AgonistsHumansMice, Inbred C57BL

Substanzen

Lymphocyte Activation Gene 3 ProteinAntigens, CDB7-H1 AntigenToll-Like Receptor AgonistsPeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Institute of Cancer Research, Henan Academy of Innovations in Medical Science, Zhengzhou 451162, China.
  • Department of Nephrology, Center of Kidney and Urology, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
  • Digestive Diseases Center, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.

ORCID-Profile: Yanfeng Gao

Förderung

  • Natural Science Foundation of Henan Province
  • Science and Technology Foundation of Shenzhen City
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • Shenzhen Medical Research Fund

Zitieren

APA

Qian, Y., Sun, Y., Wu, Y., Liu, Y., Zhou, X., Ning, H., Xiao, Y., Zhu, X., Zhou, X., Niu, X., Zhai, W., & Gao, Y. (2026). A Bispecific Peptide–Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells. Journal of Medicinal Chemistry, 69(7), 7839-7855. https://doi.org/10.1021/acs.jmedchem.5c03115

Vancouver

Qian Y, Sun Y, Wu Y, Liu Y, Zhou X, Ning H, et al. A Bispecific Peptide–Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells. Journal of Medicinal Chemistry. 2026;69(7):7839-7855. doi:10.1021/acs.jmedchem.5c03115

BibTeX
@article{Qian2026,
  author = {Qian, Yuzhen and Sun, Yixuan and Wu, Yahong and Liu, Yi and Zhou, Xiuman and Ning, Haoming and Xiao, Youmei and Zhu, Xueqin and Zhou, Xuefu and Niu, Xiaoshuang and Zhai, Wenjie and Gao, Yanfeng},
  title = {A Bispecific Peptide–Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {7},
  pages = {7839--7855},
  doi = {10.1021/acs.jmedchem.5c03115}
}
Kostenlos starten →